NCT03530514View on ClinicalTrials.gov

A Study to Examine the Safety, Tolerability and Biological Effects of REGN4461 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

113

Participants

Timeline

Start Date

April 24, 2018

Primary Completion Date

January 27, 2020

Study Completion Date

January 27, 2020

Conditions
Healthy Volunteers
Interventions
DRUG

REGN4461

REGN4461

DRUG

Placebo

Placebo-matching REGN4461

Trial Locations (1)

Unknown

Regeneron Investigational Site, Antwerp

All Listed Sponsors
lead

Regeneron Pharmaceuticals

INDUSTRY

NCT03530514 - A Study to Examine the Safety, Tolerability and Biological Effects of REGN4461 in Healthy Volunteers | Biotech Hunter | Biotech Hunter